Analysis and Forecast, 2019-2025
Global Non-Invasive Drug Delivery Devices Market by BIS Research projects the market to grow at a significant CAGR of 23.13% durin
What are the different types of non-invasive drug delivery systems available in the market, and what are the benefits offered by t
The scope of this report is centered upon conducting a detailed study of the non-invasive drug delivery devices used by patients o
4.1 Industry Ecosystem
4.1.1 Drug Delivery Device Manufacturers
4.1.2 Pharmaceutical Companies
4.1.3 Distributors
4.2 Legal and Regulatory Framework
4.3 Voice of Consortium and Associations
4.4 Patent Analysis
6.1 Assumptions and Limitations
6.2 Market Overview
6.2.1 Advent and Evolution of Drug Delivery
6.2.2 Key Findings and Emerging Trends
6.3 Market Dynamics
6.3.1 Market Drivers
6.3.1.1 Increasing Prevalence of Chronic and Lifestyle-Associated Diseases Elevating the Demand of Non-Invasive Drug Delivery Devices
6.3.1.1.1 Increase in Prevalence of Diabetes Population
6.3.1.1.2 Increase in Prevalence of Neurological Diseases
6.3.1.1.3 Increase in Prevalence of Respiratory Diseases
6.3.1.2 Growing Geriatric Population Leads to Surge in Exigency of Non-Invasive Drug Delivery Devices
6.3.1.3 Increasing Needlestick Injuries Lead to Surge in Demand of Non-Invasive Drug Delivery Devices
6.3.1.4 Increasing Demand for the Self-Administered Medication Service
6.3.1.5 Persistent Support from Government and Non-Government Organizations
6.3.2 Market Restraints
6.3.2.1 Technical Barrier to the Non-Invasive Mode of Drug Delivery
6.3.2.2 Alternative Drug Delivery Technology
6.3.3 Impact Analysis
6.3.4 Market Opportunities
6.3.4.1 Expansion into the Emerging Economies
6.3.4.2 Technological Advancement of Non-Invasive Drug Delivery Devices
6.3.4.2.1 Microneedle Patches for Vaccine Delivery
6.3.4.2.2 Organ-on-Chip
6.3.4.3 Collaboration between Pharmaceutical Companies and Drug Delivery Firms
7.1 Overview
7.2 Artificial Pancreas (Closed-Loop Insulin Pumps)
7.3 Needle-Free Injector
7.3.1 Needle-Free Injector Market (by Technology)
7.3.1.1 Gas-Based Needle-Free Injector
7.3.1.2 Spring-Based Needle-Free Injector
7.3.1.3 Other Needle-Free Injector
7.3.2 Needle-Free Injector Market (by Usability)
7.3.2.1 Reusable Needle-Free Injector
7.3.2.2 Disposable Needle-Free Injector
7.3.3 Needle-Free Injector Market (by Type)
7.3.3.1 Liquid-Based Needle-Free Injector
7.3.3.2 Powder-Based Needle-Free Injector
7.3.4 Needle-Free Injector Market (by Site of Delivery)
7.3.4.1 Subcutaneous Needle-Free Injector
7.3.4.2 Intramuscular Needle-Free Injector
7.3.4.3 Intradermal Needle-Free Injector
7.4 Digital Respiratory Devices
7.4.1 Digital Respiratory Devices Market (by Product Type)
7.4.1.1 Sensors and App
7.4.1.2 Smart Inhalers and Nebulizers
8.1 Overview
8.2 Diabetes Management
8.3 Vaccine Management
8.4 Pain Management
8.5 Respiratory Management
8.6 Others
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Rest-of-Asia-Pacific
9.5 Latin America, Middle East and Africa
10.1 Adherium Limited
10.1.1 Company Overview
10.1.2 Role of Adherium Limited in the Global Non-Invasive Drug Delivery Devices Market
10.1.3 Financials
10.1.4 SWOT Analysis
10.2 Capsule Technologies, Inc.
10.2.1 Company Overview
10.2.2 Role of Capsule Technologies, Inc. in the Global Non-Invasive Drug Delivery Devices Market
10.2.3 SWOT Analysis
10.3 Crossject S.A.
10.3.1 Company Overview
10.3.2 Role of Crossject S.A. in the Global Non-Invasive Drug Delivery Devices Market
10.3.3 Financials
10.3.4 SWOT Analysis
10.4 Diabeloop SA
10.4.1 Company overview
10.4.2 Role of Diabeloop SA in the Global Non-Invasive Drug Delivery Devices Market
10.4.3 SWOT Analysis
10.5 HNS International, Inc.
10.5.1 Company Overview
10.5.2 Role of HNS International, Inc. in the Global Non-Invasive Drug Delivery Devices Market
10.5.3 SWOT Analysis
10.6 Inovio Pharmaceuticals, Inc.
10.6.1 Company Overview
10.6.2 Role of Inovio Pharmaceuticals, Inc. in the Global Non-Invasive Drug Delivery Devices Market
10.6.3 Financials
10.6.4 SWOT Analysis
10.7 Medtronic Plc.
10.7.1 Company Overview
10.7.2 Role of Medtronic Plc. in the Non-Invasive Drug Delivery Devices Market
10.7.3 Financials
10.7.4 SWOT Analysis
10.8 Novartis AG
10.8.1 Company Overview
10.8.2 Role of Novartis AG in the Global Non-Invasive Drug Delivery Devices Market
10.8.3 Financials
10.8.4 SWOT Analysis
10.9 PenJet Corporation
10.9.1 Company Overview
10.9.2 Role of PenJet in the Global Non-Invasive Drug Delivery Devices Market
10.9.3 SWOT Analysis
10.10 PharmaJet
10.10.1 Company Overview
10.10.2 Role of Pharma Jet in the Global Non-Invasive Drug Delivery Devices Market
10.10.3 SWOT Analysis
10.11 Portal Instruments
10.11.1 Company Overview
10.11.2 Role of Portal Instruments in the Global Non-Invasive Drug Delivery Devices Market
10.11.3 SWOT Analysis
10.12 Propeller Health (A Subsidiary of ResMed)
10.12.1 Company Overview
10.12.2 Role of Propeller Health in the Global Non-Invasive Drug Delivery Devices Market
10.12.3 SWOT Analysis
10.13 Sensiron AG
10.13.1 Company Overview
10.13.2 Role of Sensiron AG in the Global Non-Invasive Drug Delivery Devices Market
10.13.3 Financials
10.13.4 SWOT Analysis
10.14 Tandem Diabetes Care, Inc.
10.14.1 Company Overview
10.14.2 Role of Tandem Diabetes Care, Inc. in the Global Non-Invasive Drug Delivery Devices Market
10.14.3 Financials
10.14.4 SWOT Analysis
10.15 Teva Pharmaceuticals Industries Ltd.
10.15.1 Company Overview
10.15.2 Role of Teva Pharmaceuticals Industries Ltd. in the Global Non-Invasive Drug Delivery Devices Market
10.15.3 Financials
10.15.4 SWOT Analysis
Table 4.1: Regulatory Authority of the Global Non-Invasive Drug Delivery Devices Market
Table 4.2: Association/ Society/ Consortium of the Global Non-Invasive Drug Delivery Devices Market
Table 5.1: Product Portfolio Analysis – Needle Free Injector
Table 5.2: Product Portfolio Analysis – Digital Inhalers and Nebulizers
Table 5.3: Different Data Revenue Streams
Table 6.1: Deaths due to Multiple Sclerosis in Key Countries, 2015-2017
Table 6.2: Prevalence of Asthma in Key Countries, 2015-2017
Table 6.3: Prevalence of COPD in Key Countries, 2015-2017
Table 6.4: Funding Initiatives by Government and Research Institutes
Table 6.5: Funding Initiatives by Public and Private Companies
Table 9.1: Prevalence of Diseases in North America, 2014-2017
Table 9.2: Prevalence of Diseases in the U.S., 2014-2017
Table 9.3: Prevalence of Diseases in Canada, 2014-2017
Table 9.4: Prevalence of Diseases in Europe, 2014-2017
Table 9.5: Prevalence of Diseases in Germany, 2014-2017
Table 9.6: Prevalence of Diseases in the U.K., 2014-2017
Table 9.7: Prevalence of Diseases in France, 2014-2017
Table 9.8: Prevalence of Diseases in Asia, 2014-2017
Table 9.9: Prevalence of Diseases in Japan, 2014-2017
Table 9.10: Prevalence of Diseases in China, 2014-2017
Table 9.11: Prevalence of Diseases in India, 2014-2017
Table 9.12: Prevalence of Diseases in Australia, 2014-2017
Figure 1: Number of People (20-79 years) with Diabetes in 2017 and 2045
Figure 2: Global Non-Invasive Drug Delivery Devices Market, 2018-2025
Figure 3: Market Drivers and Market Restraints
Figure 4: Market Share Analysis – Needle-Free Injector (by Company), 2018
Figure 5: Market Share Analysis – Digital Inhalers and Nebulizers (by Company), 2018
Figure 6: Partnerships, Alliances, and Business Expansions Share (by Company), March 2015-March 2020
Figure 7: Global Non-Invasive Drug Delivery Devices Market (by Type), 2018 and 2025
Figure 8: Global Non-Invasive Drug Delivery Devices Market (by Region), 2018 and 2025
Figure 9: Share of Patent by Ownership, January 2016-December 2019
Figure 2.1: Global Non-Invasive Drug Delivery Devices Market Segmentation
Figure 3.1: Global Non-Invasive Drug Delivery Devices Market Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Total Number of Companies Profiles
Figure 3.5: Assumptions and Limitations
Figure 4.1: Share of Patent by Ownership, January 2016-December 2019
Figure 5.1: Share of Key Developments and Strategies, March 2015-March 2020
Figure 5.2: Partnerships, Alliances, and Business Expansions Share (by Company), March 2015-March 2020
Figure 5.3: Regulatory and Legal (by Company), March 2015-March 2020
Figure 5.4: Merger and Acquisition Activities (by Company), March 2015-March 2020
Figure 5.5: New Offerings Share (by Company), March 2015-March 2020
Figure 5.6: Fundings Share (by Company), March 2015-March 2020
Figure 5.7: Procurement and Sales (by Company), March 2015-March 2020
Figure 5.8: Market Share Analysis – Needle-Free Injector (by Company), 2018
Figure 5.9: Market Share Analysis – Digital Inhalers and Nebulizers (by Company), 2018
Figure 5.10: Price vs. Product Analysis – Needle-Free Injector
Figure 5.11: Shelf Life Analysis – Needle-Free Injector
Figure 5.12: Pricing Analysis – Digital Inhalers
Figure 5.13: Smart Inhaler Value Propositions for Stakeholders
Figure 5.14: Smart Inhalers and Nebulizers – An Important Element of System for Predicting Disease Worsening in Individuals
Figure 6.1: Emergence of Needle-Free Technology
Figure 6.2: Number of People (20-79 years) with Diabetes in 2017, and 2045
Figure 6.3: Geriatric Population (60 years and above) Worldwide in Different Regions, 2000, 2015, 2030, and 2050
Figure 6.4: Impact Analysis
Figure 7.1: Global Non-Invasive Drug Delivery Devices Market, (by Type), 2018 and 2025
Figure 7.2: Drivers and Restraints for the Artificial Pancreas Market
Figure 7.3: Global Artificial Pancreas Market, 2018-2025
Figure 7.4: Drivers and Restraints for the Needle-Free Injectors Market
Figure 7.5: Global Needle-Free Injector Market, 2018-2025
Figure 7.6: Segmentation of Needle-Free Injector Market (by Technology)
Figure 7.7: Global Needle-Free Injector Market (by Technology), 2018 and 2025
Figure 7.8: Global Gas-Based Needle-Free Injector Market, 2018-2025
Figure 7.9: Global Spring-Based Needle-Free Injector Market, 2018-2025
Figure 7.10: Global Other Needle-Free Injector Market, 2018-2025
Figure 7.11: Segmentation of Needle-Free Injector Market (by Usability)
Figure 7.12: Global Needle-free Injector Market (by Usability), 2018 and 2025
Figure 7.13: Global Reusable Needle-Free Injector Market, 2018-2025
Figure 7.14: Global Disposable Needle-Free Injector Market, 2018-2025
Figure 7.15: Segmentation of Needle-Free Injector Market (by Type)
Figure 7.16: Global Needle-Free Injector Market (by Type), 2018 and 2025
Figure 7.17: Global Liquid-Based Needle-Free Injector Market, 2018-2025
Figure 7.18: Global Powder-Based Needle-Free Injector Market, 2018-2025
Figure 7.19: Segmentation of Needle-Free Injector Market (by Site of Delivery)
Figure 7.20: Global Needle-Free Injector Market (by Site of Delivery), 2018 and 2025
Figure 7.21: Global Subcutaneous Needle-Free Injector Market, 2018-2025
Figure 7.22: Global Intramuscular Needle-Free Injector Market, 2018-2025
Figure 7.23: Global Intradermal Needle-Free Injector Market, 2018-2025
Figure 7.24: Drivers and Restraints for the Digital Respiratory Devices Market
Figure 7.25: Global Digital Respiratory Devices Market, 2018-2025
Figure 7.26: Segmentation of Digital Respiratory Devices Market (by Product Type)
Figure 7.27: Global Digital Respiratory Devices Market, by Sensor and App, 2018-2025
Figure 7.28: Global Digital Respiratory Devices Market, (by Digital Respiratory Devices), 2018-2025
Figure 8.1: Global Non-Invasive Drug Delivery Devices Market for Diabetes Management, 2018-2025
Figure 8.2: Global Non-Invasive Drug Delivery Devices Market for Vaccine Management, 2018-2025
Figure 8.3: Global Non-Invasive Drug Delivery Devices Market for Pain Management, 2018-2025
Figure 8.4: Global Non-Invasive Drug Delivery Devices Market for Respiratory Management, 2018-2025
Figure 8.5: Global Non-Invasive Drug Delivery Devices Market for Others, 2018-2025
Figure 9.1: Global Non-Invasive Drug Delivery Devices Market Scenario, 2018 to 2025
Figure 9.2: North America Non-Invasive Drug Delivery Devices Market, 2018-2025
Figure 9.3: North America: Market Dynamics
Figure 9.4: U.S. Non-Invasive Drug Delivery Devices Market, 2018-2025
Figure 9.5: Canada Non-Invasive Drug Delivery Devices Market, 2018-2025
Figure 9.6: Europe Non-Invasive Drug Delivery Devices Market, 2018-2025
Figure 9.7: Europe: Market Dynamics
Figure 9.8: Germany Non-Invasive Drug Delivery Devices Market, 2018-2025
Figure 9.9: U.K. Non-Invasive Drug Delivery Devices Market, 2018-2025
Figure 9.10: France Non-Invasive Drug Delivery Devices Market, 2018-2025
Figure 9.11: Rest-of-Europe Non-Invasive Drug Delivery Devices Market, 2018-2025
Figure 9.12: Asia-Pacific Non-Invasive Drug Delivery Devices Market, 2018-2025
Figure 9.13: Asia-Pacific: Market Dynamics
Figure 9.14: Japan Non-Invasive Drug Delivery Devices Market, 2018-2025
Figure 9.15: China Non-Invasive Drug Delivery Devices Market, 2018-2025
Figure 9.16: India Non-Invasive Drug Delivery Devices Market, 2018-2025
Figure 9.17: Australia Non-Invasive Drug Delivery Devices Market, 2018-2025
Figure 9.18: Rest-of-Asia-Pacific Non-Invasive Drug Delivery Devices Market, 2018-2025
Figure 9.19: Latin America, Middle East and Africa Non-Invasive Drug Delivery Devices Market, 2018-2025
Figure 9.20: Latin America, Middle East and Africa: Market Dynamics
Figure 10.1: Adherium Limited: Product Offerings
Figure 10.2: Overall Financials, 2016-2018
Figure 10.3: R&D Expense, 2016-2018
Figure 10.4: Adherium Limited: SWOT Analysis
Figure 10.5: Capsule Technologies, Inc.: Product Offerings
Figure 10.6: Capsule Technologies, Inc.: SWOT Analysis
Figure 10.7: Crossject S.A.: Product Offerings
Figure 10.8: Overall Financials, 2017-2019
Figure 10.9: Crossject S.A.: SWOT Analysis
Figure 10.10: Diabeloop SA: Product Offerings
Figure 10.11: Diabeloop SA : SWOT Analysis
Figure 10.12: HNS International, Inc.: Product Offerings
Figure 10.13: HNS International, Inc.: SWOT Analysis
Figure 10.14: Inovio Pharmaceuticals, Inc.: Product Offerings
Figure 10.15: Inovio Pharmaceuticals, Inc.: Overall Financials, 2017-2019
Figure 10.16: Inovio Pharmaceuticals, Inc.: R& D Expense, 2017-2019
Figure 10.17: Inovio Pharmaceuticals, Inc.: SWOT Analysis
Figure 10.18: Medtronic Plc.: Product Portfolio
Figure 10.19: Medtronic Plc.: Overall Financials, 2017-2019
Figure 10.20: Medtronic Plc.: Revenue (by Segment), 2017-2019
Figure 10.21: Medtronic Plc.: Revenue (by Region), 2017-2019
Figure 10.22: Medtronic Plc.: Research and Development Expense, 2017-2019
Figure 10.23: Medtronic Plc.: SWOT Analysis
Figure 10.24: Novartis AG: Product Offerings
Figure 10.25: Novartis AG: Overall Financials, 2017-2019
Figure 10.26: Novartis AG Net Revenue (by Business Segment), 2016-2018
Figure 10.27: Novartis AG: Net Revenue (by Region), 2016-2018
Figure 10.28: Novartis AG: R&D Expense, 2016-2018
Figure 10.29: Novartis AG: SWOT Analysis
Figure 10.30: PenJet: Product Offerings
Figure 10.31: PenJet :SWOT Analysis
Figure 10.32: Pharma Jet: Product Offerings
Figure 10.33: PharmaJet: SWOT Analysis
Figure 10.34: Portal Instruments: Product Offerings
Figure 10.35: Portal Instruments: SWOT Analysis
Figure 10.36: Propeller Health: Product Offerings
Figure 10.37: Propeller Health: SWOT Analysis
Figure 10.38: Sensirion AG: Product Offerings
Figure 10.39: Sensirion AG: Overall Financials, 2017-2019
Figure 10.40: Sensirion AG: Net Revenue (by Business Segment), 2017-2019
Figure 10.41: Sensirion AG: Net Revenue (by Region), 2017-2019
Figure 10.42: Sensirion AG: R&D Expense, 2017-2019
Figure 10.43: Sensirion AG: SWOT Analysis
Figure 10.44: Tandem Diabetes Care, Inc.: Overall Product Offerings
Figure 10.45: Tandem Diabetes Care, Inc.: Overall Financials, 2016-2018
Figure 10.46: Tandem Diabetes Care, Inc.: Research and Development Expense, 2017-2019
Figure 10.47: Tandem Diabetes Care, Inc.: SWOT Analysis
Figure 10.48: Teva Pharmaceuticals Industries Ltd.: Overall Product Offerings
Figure 10.49: Teva Pharmaceuticals Industries Ltd.: Overall Financials, 2016-2018
Figure 10.50: Teva Pharmaceuticals Industries Ltd.: Net Revenue (by Business Segment), 2016-2018
Figure 10.51: Teva Pharmaceuticals Industries Ltd.: Research and Development Expense, 2016-2018
Figure 10.52: Teva Pharmaceuticals Industries Ltd.: SWOT Analysis
The global digital respiratory devices market was valued at approximately $8.5 million in 2018...
The global injectable drug delivery market was estimated at $16.73 billion in 2016 and is...
The global drug infusion systems market was estimated to be $8.1 billion in 2016 and is...
With the advancement of drug delivery technologies and blood glucose diagnostic devices, the...
Analysis and Forecast, 2019-2025
